HeMeTekx was founded to make essential medical tests, which influence 70% of medical decisions, more accessible and timely for everyone. Leveraging advanced nanobiosensor technology and AI, HeMeTekx has developed a user-friendly point-of-care testing platform that can rapidly measure critical biomarkers, similar to using a glucose meter. Its first application targets heart failure care, delivering results in just 15 minutes from a finger-prick blood sample, significantly reducing delays in diagnosis and treatment.